[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mimedx Group Inc (MDXG)

Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 623,853
  • Shares Outstanding, K 145,760
  • Annual Sales, $ 418,630 K
  • Annual Income, $ 48,580 K
  • EBIT $ 10 M
  • EBITDA $ 24 M
  • 60-Month Beta 1.45
  • Price/Sales 1.50
  • Price/Cash Flow 7.80
  • Price/Book 2.92

Options Overview Details

View History
  • Implied Volatility 94.34% (-100.39%)
  • Historical Volatility 35.42%
  • IV Percentile 15%
  • IV Rank 8.75%
  • IV High 840.25% on 06/05/26
  • IV Low 22.85% on 09/04/25
  • Expected Move (DTE 8) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 1,744
  • Open Int (30-Day) 1,687
  • Expected Range 4.22 to 4.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.15
  • Growth Rate Est. (year over year) +665,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.76 +11.70%
on 07/30/26
4.49 -6.35%
on 08/03/26
+0.12 (+2.94%)
since 07/13/26
3-Month
3.48 +20.69%
on 06/01/26
4.49 -6.35%
on 08/03/26
+0.68 (+19.32%)
since 05/13/26
52-Week
3.03 +38.84%
on 04/29/26
7.97 -47.30%
on 11/05/25
-3.07 (-42.23%)
since 08/13/25

Most Recent Stories

More News
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Sanara MedTech ...

MDXG : 4.20 (-1.87%)
SMTI : 34.16 (-0.50%)
MiMedx: Q2 Earnings Snapshot

MiMedx: Q2 Earnings Snapshot

MDXG : 4.20 (-1.87%)
MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Reports  Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference...

MDXG : 4.20 (-1.87%)
SMTI : 34.16 (-0.50%)
MIMEDX to Acquire Sanara MedTech

Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly...

MDXG : 4.20 (-1.87%)
SMTI : 34.16 (-0.50%)
Can MiMedx Prove Its Wound Care Business Still Exists After the Reimbursement Shock?

Barchart Research What to Expect from MDXG Earnings MDXG Generated July 28, 2026 Current Price $4.36 Consensus Rating Strong Buy Average Move 8.63% Can MiMedx Prove Its Wound Care Business Still Exists...

MDXG : 4.20 (-1.87%)
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the...

MDXG : 4.20 (-1.87%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

NEW YORK , May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG). Such investors are advised...

MDXG : 4.20 (-1.87%)
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the  Craig-Hallum...

MDXG : 4.20 (-1.87%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

NEW YORK , May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG).  Such investors are advised...

MDXG : 4.20 (-1.87%)
MIMEDX Announces Launch of G4Derm® Plus

Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company’s Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE)...

MDXG : 4.20 (-1.87%)

Business Summary

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the...

See More

Key Turning Points

3rd Resistance Point 4.46
2nd Resistance Point 4.42
1st Resistance Point 4.35
Last Price 4.20
1st Support Level 4.24
2nd Support Level 4.20
3rd Support Level 4.13

See More

52-Week High 7.97
Fibonacci 61.8% 6.08
Fibonacci 50% 5.50
Fibonacci 38.2% 4.91
Last Price 4.20
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.